scholarly journals Assessing Prior Pain Visits and Medical History Risk Factors for Opioid Overdose

2018 ◽  
Vol 10 (1) ◽  
Author(s):  
Andrew Walsh

Objective: Identifying text features of emergency department visits associated with risk of future drug overdose.Introduction: Opioid overdoses are a growing cause of mortality in the United States.1 Medical prescriptions for opioids are a risk factor for overdose2. This observation raises concerns that patients may seek multiple opioid prescriptions, possibly increasing their overdose risk. One route for obtaining those prescriptions is visiting the emergency department (ED) for pain-related complaints. Here, two hypotheses related to prescription seeking and overdoses are tested. (1) Overdose patients have a larger number of prior ED visits than matched controls. (2) Overdose patients have distinct patterns of pain-related complaints compared to matched controls.Methods: ED registrations were collected via the EpiCenter syndromic surveillance system. Regular expression searches on chief complaints identified overdose visits. Overdose visits were matched with control visits from the same facility with maximal similarity of gender, age, home location and arrival time.A year of prior ED visits for cases and controls were matched using facility-specific patient identifiers or birthdate, gender and home location.Patient history chief complaints were sanitized to standardize spelling, expand abbreviations and consolidate phrases. Word frequency comparisons between groups identified candidate terms for modeling.Odds ratios of patient history terms were calculated with univariate logistic regression. Multivariate lasso logistic regression selected covariates for prediction. These models were fit to data from one quarter and cutoffs for covariate inclusion were validated on the following quarter’s data. Model predictions were validated on a 1% sample of ED registrations from the next quarter.Results: Quarter three of 2016 yielded 23,769 overdose ED visits and matching controls; quarter four yielded 21,957 pairs; and 15,824 ED visits were sampled from the first quarter of 2017 including 130 overdose visits.Contrary to expectations, patients in the control group averaged 0.7 additional ED visits in the prior year relative to controls; this pattern was consistent across quarters and regardless of how prior visits were matched (Fig 1).Prior visits for various pain categories were also more common among control patients than overdose patients (e.g. odds ratio for “back pain”: 0.78). Terms associated with drug use (e.g. “detox” odds ratio: 2.66) and mental health concerns (e.g. “psychological” odds ratio: 4.28) were most consistently overrepresented in the history of overdose patients (Table 1). Terms associated with chronic disease were most overrepresented in the history of control patients (Table 2).The best predictive model achieved a sensitivity of 57% and a specificity of 86% on test data (Fig 2).Conclusions: While a history of more overall ED visits and more ED visits related to pain were not associated with overdose ED visits, vocabulary of prior ED visits did predict future overdose ED visits. Performance of predictive models exceeded expectations, given the relative scarcity of overdoses among ED visits and the simplicity of chief complaints used for prediction. The correlation between past and future overdose visits highlights the need for targeted intervention to break addiction cycles.

2017 ◽  
Vol 9 (1) ◽  
Author(s):  
Andrew Walsh

ObjectiveTo identify heroin- and opioid-related emergency department visitsusing pre-diagnositc data. To demonstrate the value of clinical notesto public health surveillance and situational awareness.IntroductionOverdoses of heroin and prescription opioids are a growingcause of mortality in the United States. Deaths from opioids havecontributed to a rise in the overall mortality rate of middle-aged whitemales during an era when other demographics are experiencing lifeexpectancy gains.1 A successful public health intervention to reversethis mortality trend requires a detailed understanding of whichpopulations are most affected and where those populations live. Whilemortality is the most relevant metric for this emerging challenge,increased burden on laboratory facilities can create significantdelays in obtaining confirmation of which patients died from opioidoverdoses.Emergency department visits for opioid overdoses can provide amore timely proxy measure of overall opioid use. Unfortunately, chiefcomplaints do not always contain an indication of opioid involvement.Overdose patients are not always conscious at registration whichlimits the amount of information they can provide. Menu-drivenregistration systems can lump all overdoses together regardless ofsubstance. A more complete record of the emergency departmentinteraction, such as that provided by triage notes, could provide theinformation necessary to differentiate opioid-related visits from otheroverdoses.MethodsEmergency department registration data was collected fromhospitals via the EpiCenter syndromic surveillance system. Thisdata included chief complaints, triage notes, discharge disposition,and preliminary diagnosis codes. Data elements were linked across agiven visit using patient identifiers and visit numbers as appropriate.Heroin- and opioid-related indicators were identified in chiefcomplaints and triage notes using regular expressions. These wereseparated into three categories: visits with an indication of overdose,visits for withdrawal symptoms, and visits where opioids werementioned in some other context such as history of use. Thesecategories were designed to be mutually exclusive.Regular expression classification results were compared toclassifications based on opioid-related diagnosis codes.ResultsA total of 2,934,610 ED registrations with triage notes and diagnosiscodes were collected from 82 hospitals between January 1, 2015 andAugust 21, 2016. Of these encounters, 24,012 referenced opioid usein some way; 16,718 mentioned heroin specifically; 3,663 mentionedfentanyl specifically; and 5,350 mentioned opioids generically.Table 1 shows the distribution of heroin-related ED visits acrosscategories and source of the indicator. Column totals are not the sumof individual row amounts; they have been adjusted so that a givenregistration is only counted once.Table 2 shows the overlap of heroin-related ED visits betweensources of indicators. Triage notes showed the least overlap with theother two sources, while chief complaints showed the most.ConclusionsWhile it is possible to find indicators of opioid use or overdosein chief complaint data, that field alone does not provide totalinformation about which ED visits are related to opioids. Triagenotes in particular indicate opioid involvement in a large numberof visits not identified by other data sources. While many of theseare simply mentions of opioids, possibly indicating past history ofuse or even in some cases just that questions about opioid use wereasked, a substantial number of visits with overdose indicators werealso detected solely from triage note data. These results suggest thattriage notes can be a valuable additional data source for more complexhealth concerns such as opioid drug use.Table 1: Heroin-Related ED Visits By Indicator Source and CategoryTable 2: Overlap of Heroin-Related ED Visits between Indicators


Author(s):  
Raghav Tripathi ◽  
Konrad D Knusel ◽  
Harib H Ezaldein ◽  
Jeremy S Bordeaux ◽  
Jeffrey F Scott

Abstract Background Limited information exists regarding the burden of emergency department (ED) visits due to scabies in the United States. The goal of this study was to provide population-level estimates regarding scabies visits to American EDs. Methods This study was a retrospective analysis of the nationally representative National Emergency Department Sample from 2013 to 2015. Outcomes included adjusted odds for scabies ED visits, adjusted odds for inpatient admission due to scabies in the ED scabies population, predictors for cost of care, and seasonal/regional variation in cost and prevalence of scabies ED visits. Results Our patient population included 416 017 218 ED visits from 2013 to 2015, of which 356 267 were due to scabies (prevalence = 85.7 per 100 000 ED visits). The average annual expenditure for scabies ED visits was $67 125 780.36. The average cost of care for a scabies ED visit was $750.91 (±17.41). Patients visiting the ED for scabies were most likely to be male children from lower income quartiles and were most likely to present to the ED on weekdays in the fall, controlling for all other factors. Scabies ED patients that were male, older, insured by Medicare, from the highest income quartile, and from the Midwest/West were most likely to be admitted as inpatients. Older, higher income, Medicare patients in large Northeastern metropolitan cities had the greatest cost of care. Conclusion This study provides comprehensive nationally representative estimates of the burden of scabies ED visits on the American healthcare system. These findings are important for developing targeted interventions to decrease the incidence and burden of scabies in American EDs.


2019 ◽  
Vol 112 (9) ◽  
pp. 938-943 ◽  
Author(s):  
Vikram Jairam ◽  
Daniel X Yang ◽  
James B Yu ◽  
Henry S Park

Abstract Background Patients with cancer may be at risk of high opioid use due to physical and psychosocial factors, although little data exist to inform providers and policymakers. Our aim is to examine overdoses from opioids leading to emergency department (ED) visits among patients with cancer in the United States. Methods The Healthcare Cost and Utilization Project Nationwide Emergency Department Sample was queried for all adult cancer-related patient visits with a primary diagnosis of opioid overdose between 2006 and 2015. Temporal trends and baseline differences between patients with and without opioid-related ED visits were evaluated. Multivariable logistic regression analysis was used to identify risk factors associated with opioid overdose. All statistical tests were two-sided. Results Between 2006 and 2015, there were a weighted total of 35 339 opioid-related ED visits among patients with cancer. During this time frame, the incidence of opioid-related ED visits for overdose increased twofold (P < .001). On multivariable regression (P < .001), comorbid diagnoses of chronic pain (odds ratio [OR] 4.51, 95% confidence interval [CI] = 4.13 to 4.93), substance use disorder (OR = 3.54, 95% CI = 3.28 to 3.82), and mood disorder (OR = 3.40, 95% CI = 3.16 to 3.65) were strongly associated with an opioid-related visit. Patients with head and neck cancer (OR = 2.04, 95% CI = 1.82 to 2.28) and multiple myeloma (OR = 1.73, 95% CI = 1.32 to 2.26) were also at risk for overdose. Conclusions Over the study period, the incidence of opioid-related ED visits in patients with cancer increased approximately twofold. Comorbid diagnoses and primary disease site may predict risk for opioid overdose.


2019 ◽  
Vol 134 (6) ◽  
pp. 685-694
Author(s):  
Shaoman Yin ◽  
Laurie Barker ◽  
Eyasu H. Teshale ◽  
Ruth B. Jiles

Objective: Emergency departments (EDs) are critical settings for hepatitis C care in the United States. We assessed trends and characteristics of hepatitis C–associated ED visits during 2006-2014. Methods: We used data from the 2006-2014 Nationwide Emergency Department Sample to estimate numbers, rates, and costs of hepatitis C–associated ED visits, defined by either first-listed diagnosis of hepatitis C or all-listed diagnosis of hepatitis C. We assessed trends by demographic characteristics, liver disease severity, and patients’ disposition by using joinpoint analysis, and we calculated the average annual percentage change (AAPC) from 2006 to 2014. Results: During 2006-2014, the rate per 100 000 visits of first-listed and all-listed hepatitis C–associated ED visits increased significantly from 10.1 to 25.4 (AAPC = 13.0%; P < .001) and from 484.4 to 631.6 (AAPC = 3.4%; P < .001), respectively. Approximately 70% of these visits were made by persons born during 1945-1965 (baby boomers); 30% of visits were made by Medicare beneficiaries and 40% by Medicaid beneficiaries. Significant rate increases were among visits by baby boomers (first-listed: AAPC = 13.8%; all-listed: AAPC = 2.6%), persons born after 1965 (first-listed: AAPC = 14.3%; all-listed: AAPC = 9.2%), Medicare beneficiaries (first-listed: AAPC = 18.0%; all-listed: AAPC = 3.9%), and persons hospitalized after ED visits (first-listed: AAPC = 20.0%; all-listed: AAPC = 2.3%; all P < .001). Increasing proportions of compensated cirrhosis were among visits by baby boomers (first-listed: AAPC = 11.5%; all-listed: AAPC = 6.3%). Annual hepatitis C–associated total ED costs increased by 400.0% (first-listed) and 192.0% (all-listed) during 2006-2014. Conclusion: Public health efforts are needed to address the growing burden of hepatitis C care in the ED.


2020 ◽  
pp. 155982762094218
Author(s):  
Briana L. Moreland ◽  
Ramakrishna Kakara ◽  
Yara K. Haddad ◽  
Iju Shakya ◽  
Gwen Bergen

Introduction. Falls among older adults (age ≥65) are a common and costly health issue. Knowing where falls occur and whether this location differs by sex and age can inform prevention strategies. Objective. To determine where injurious falls that result in emergency department (ED) visits commonly occur among older adults in the United States, and whether these locations differ by sex and age. Methods. Using 2015 National Electronic Injury Surveillance System-All Injury Program data we reviewed narratives for ED patients aged ≥65 who had an unintentional fall as the primary cause of injury. Results. More fall-related ED visits (71.6%) resulted from falls that occurred indoors. A higher percentage of men’s falls occurred outside (38.3%) compared to women’s (28.4%). More fall-related ED visits were due to falls at home (79.2%) compared to falls not at home (20.8%). The most common locations for a fall at home were the bedroom, bathroom, and stairs. Conclusion. The majority of falls resulting in ED visits among older adults occurred indoors and varied by sex and age. Knowing common locations of injurious falls can help older adults and caregivers prioritize home modifications. Understanding sex and age differences related to fall location can be used to develop targeted prevention messages.


2019 ◽  
Vol 37 (15_suppl) ◽  
pp. 6579-6579
Author(s):  
Vikram Jairam ◽  
Daniel X. Yang ◽  
James B. Yu ◽  
Henry S. Park

6579 Background: Patients with cancer may be at high risk of opioid dependence due to physical and psychosocial factors, although little data exists to inform providers and policymakers. Our aim is to examine overdoses from prescription and synthetic opiates leading to emergency department (ED) visits among patients with cancer in the United States. Methods: The Healthcare Cost and Utilization Project Nationwide Emergency Department Sample (HCUP-NEDS) was queried for all patient visits with a primary diagnosis of prescription or synthetic opioid overdose between 2006 and 2015. Baseline differences between patients with and without cancer were assessed using chi-square and ANOVA testing. Overdose rates by primary cancer site were normalized using prevalence data from the Surveillance, Epidemiology, and End Results (SEER) Program. Weighted frequencies were used to create national estimates for all data analyses. Results: There were 682,820 weighted ED visits for synthetic opioid overdose, among which 34,547 (5.1%) visits were also associated with a diagnosis of cancer. During this timeframe, ED visits for opioid overdose among patients with cancer increased 2.5-fold, compared to 1.7-fold among those without cancer. 16.5% of patients with cancer had metastatic disease. Patients with cancer presenting for opioid overdose had higher risk of hospital admission (74.8% vs 49.6%), respiratory intubation (13.2% vs 12.2%), mortality (2.1% vs 1.1%), and cost-of-hospital-stay ($32,665 vs $31,824) compared to their non-cancer counterparts (all P < 0.05). Primary cancers with the highest normalized overdose rates (ED visits per 10,000 patients) were esophagus (134), liver & intrahepatic bile duct (124), and cervical cancer (124). Other common cancers had the following normalized overdose rates: lung (105), head and neck (70), and breast (26). Conclusions: Approximately 5% of all ED visits due to prescription and synthetic opioid overdose are among patients with cancer. The rate of increase in ED visits due to opioid overdose from cancer patients was nearly 50% higher than that from non-cancer patients over the 10-year study period. Patients with esophageal, liver, and cervical cancer may be at highest risk.


2021 ◽  
Vol 111 (3) ◽  
pp. 485-493
Author(s):  
Ashley Schappell D'Inverno ◽  
Nimi Idaikkadar ◽  
Debra Houry

Objectives. To report trends in sexual violence (SV) emergency department (ED) visits in the United States. Methods. We analyzed monthly changes in SV rates (per 100 000 ED visits) from January 2017 to December 2019 using Centers for Disease Control and Prevention’s National Syndromic Surveillance Program data. We stratified the data by sex and age groups. Results. There were 196 948 SV-related ED visits from January 2017 to December 2019. Females had higher rates of SV-related ED visits than males. Across the entire time period, females aged 50 to 59 years showed the highest increase (57.33%) in SV-related ED visits, when stratified by sex and age group. In all strata examined, SV-related ED visits displayed positive trends from January 2017 to December 2019; 10 out of the 24 observed positive trends were statistically significant increases. We also observed seasonal trends with spikes in SV-related ED visits during warmer months and declines during colder months, particularly in ages 0 to 9 years and 10 to 19 years. Conclusions. We identified several significant increases in SV-related ED visits from January 2017 to December 2019. Syndromic surveillance offers near-real-time surveillance of ED visits and can aid in the prevention of SV.


2021 ◽  
Author(s):  
Leslie W. Suen ◽  
Thibaut Davy-Mendez ◽  
Kathy T. LeSaint ◽  
Elise D. Riley ◽  
Phillip Coffin

Abstract Background Drug-related emergency department (ED) visits are escalating, especially for stimulant use (i.e., cocaine and psychostimulants such as methamphetamine). We sought to characterize rates, presentation, and management of US ED visits related to cocaine and psychostimulant use, compared to opioid use. Methods We used 2008–2018 National Hospital Ambulatory Medical Care Survey data to identify a nationally representative sample of ED visits related to cocaine and psychostimulant use, with opioids as the comparator. We excluded visits related to ≥2 of the three possible drug categories. We estimated annual rate trends using unadjusted Poisson regression; described demographics, presenting concerns, and management; and determined associations between drug-type and presenting concerns (categorized as psychiatric, neurologic, cardiopulmonary, and drug toxicity/withdrawal) using logistic regression, adjusting for age, sex, race/ethnicity, and homelessness. Results Cocaine-related ED visits did not significantly increase, while psychostimulant-related ED visits increased from 2008 to 2018 (2.2 visits per 10,000 population to 12.9 visits per 10,000 population; p < 0.001). Cocaine-related ED visits had higher usage of cardiac testing, while psychostimulant-related ED visits had higher usage of chemical restraints than opioid-related ED visits. Cocaine- and psychostimulant-related ED visits had greater odds of presenting with cardiopulmonary concerns (cocaine adjusted odds ratio [aOR] 2.95, 95% CI 1.70–5.13; psychostimulant aOR 2.46, 95% CI 1.42–4.26), while psychostimulant-related visits had greater odds of presenting with psychiatric concerns (aOR 2.69; 95% CI 1.83–3.95) and lower odds of presenting with drug toxicity/withdrawal concerns (aOR 0.47, 95%CI 0.30–0.73) compared to opioid-related ED visits. Conclusion Presentations for stimulant-related ED visits differ from opioid-related ED visits: compared to opioids, ED presentations related to cocaine and psychostimulants are less often identified as related to drug toxicity/withdrawal and more often require interventions to address acute cardiopulmonary and psychiatric complications.


2020 ◽  
Vol 125 (2) ◽  
pp. 103-108
Author(s):  
Thuy Quynh N. Do ◽  
Catharine Riley ◽  
Pangaja Paramsothy ◽  
Lijing Ouyang ◽  
Julie Bolen ◽  
...  

Abstract Using national data, we examined emergency department (ED) encounters during 2006–2011 for which a diagnosis code for fragile X syndrome (FXS) was present (n = 7,217). Almost half of ED visits coded for FXS resulted in hospitalization, which is much higher than for ED visits not coded for FXS. ED visits among females coded for FXS were slightly more likely to result in hospitalization. These findings underscore the importance of surveillance systems that could accurately identify individuals with FXS, track healthcare utilization and co-occurring conditions, and monitor quality of care in order to improve care and reduce FXS-associated morbidity.


2016 ◽  
Vol 43 (8) ◽  
pp. 1589-1592 ◽  
Author(s):  
Sadao Jinno ◽  
Kohei Hasegawa ◽  
Tuhina Neogi ◽  
Tadahiro Goto ◽  
Maureen Dubreuil

Objective.To examine temporal trends in the rate of gout emergency department (ED) visits and charges in the United States between 2006 and 2012.Methods.A serial cross-sectional analysis of the Nationwide Emergency Department Sample.Results.The rate of ED visits for gout in adults overall increased from 75.0 to 85.4 per 100,000 persons over the study period (14% increase, p < 0.001), and increased 29% for those aged 45–54 years. Nationwide ED charges increased from $156 million to $281 million (80% increase, p < 0.001).Conclusion.Between 2006 and 2012, the rate of gout ED visits increased among US adults, most notably in those aged 45–54 years.


Sign in / Sign up

Export Citation Format

Share Document